Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · IEX Real-Time Price · USD
27.51
+0.49 (1.81%)
At close: Mar 28, 2024, 4:00 PM
28.00
+0.49 (1.78%)
After-hours: Mar 28, 2024, 7:34 PM EDT

Intellia Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Net Income
-481.19-474.19-267.89-134.23-99.53-85.34-67.54-31.63-12.4
Depreciation & Amortization
8.987.576.896.315.594.462.991.10.33
Share-Based Compensation
134.0591.447.0119.915.0917.0515.326.721.31
Other Operating Activities
-55.9241.93-11.0458.11-24.392.58-16.0559.929
Operating Cash Flow
-394.09-333.29-225.03-49.91-103.24-61.26-65.2836.11-1.76
Capital Expenditures
-13.99-13.41-12.76-3.59-6.79-6.23-10.09-6.17-2.55
Acquisitions
0-44.83-3000000
Change in Investments
-17.36218.55-535.02-210.931.97-254.56000
Investing Cash Flow
-31.35160.31-550.78-214.4925.18-260.78-10.09-6.17-2.55
Share Issuance / Repurchase
126.39580.31734.66370.2275.3439.2142.16167.75-0.6
Other Financing Activities
3.932.652.021.561.091.020.83-0.4470.89
Financing Cash Flow
130.32582.96736.69371.7876.4340.22142.98167.370.29
Net Cash Flow
-295.11409.98-39.12107.38-1.63-281.8267.61197.2565.97
Free Cash Flow
-408.07-346.7-237.79-53.5-110.03-67.48-75.3729.94-4.32
Free Cash Flow Margin
-1124.94%-665.17%-719.41%-92.25%-255.28%-221.74%-288.57%181.71%-71.43%
Free Cash Flow Per Share
-4.60-4.50-3.35-0.96-2.33-1.57-2.091.35-17.77
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).